Laman Utama300601 โข SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Tutup sebelumnya
ยฅ15.59
Julat hari
ยฅ15.31 - ยฅ15.67
Julat tahun
ยฅ13.10 - ยฅ21.12
Permodalan pasaran
17.41B CNY
Bilangan Purata
12.41J
Nisbah P/E
-
Hasil dividen
0.58%
Pertukaran utama
SHE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CNY) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 671.38J | -17.74% |
Perbelanjaan pengendalian | 425.29J | -2.76% |
Pendapatan bersih | 11.62J | -93.74% |
Margin untung bersih | 1.73 | -92.40% |
Pendapatan bagi setiap syer | โ | โ |
EBITDA | 212.79J | -40.14% |
Kadar cukai berkesan | -3,472.08% | โ |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CNY) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.65B | 431.20% |
Jumlah aset | 14.13B | -2.63% |
Jumlah liabiliti | 4.52B | -5.87% |
Jumlah ekuiti | 9.61B | โ |
Syer tertunggak | 1.12B | โ |
Harga kepada buku | 1.81 | โ |
Pulangan pada aset | 2.39% | โ |
Pulangan pada modal | 2.94% | โ |
Aliran Tunai
Perubahan bersih dalam tunai
| (CNY) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 11.62J | -93.74% |
Tunai daripada operasi | 286.87J | 60.54% |
Tunai daripada pelaburan | 676.05J | 357.44% |
Tunai daripada pembiayaan | -44.23J | -4.17% |
Perubahan bersih dalam tunai | 918.51J | 825.91% |
Aliran tunai bebas | -1.08B | 43.85% |
Perihal
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the OxfordโAstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Diasaskan
8 Sep 1992
Tapak web
Pekerja
1,913
